TribLIVE

| USWorld


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Study: Denying anti-depressants for teens, young adults raises risk of suicides

Daily Photo Galleries

By The Washington Post
Thursday, June 19, 2014, 12:01 a.m.
 

Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.

Because of FDA warnings about SSRIs ­— selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.

 

 
 


Show commenting policy

Most-Read Nation

  1. North Korea may have key to nuclear missile, general says
  2. Lawyer turns down AG post
  3. Vehicle smashes Commandments on capitol grounds in Oklahoma City
  4. Seattle area school homecoming ‘prince’ guns down classmates
  5. 1686 shipwreck ‘like dinosaur’ being rebuilt for museum
  6. Washington city takes stock of damage from rare tornado
  7. Warhol bodyguard sued over hidden artwork
  8. New York, New Jersey order 21-day quarantine of all in contact with Ebola virus
  9. Philadelphia Mafia figure returned to prison for meeting friend
  10. Hatchet attack was terror, NYPD says
  11. 2 California deputies slain, suspect captured
Subscribe today! Click here for our subscription offers.